Skip to main content

Physician Search

 


Displaying 1 - 4 of 4

A Phase II/III Study of Peri-operative Nivolumab and Ipilimumab in Patients with Locoregional Esophageal and Gastroesophageal Junction Adenocarcinoma

Multiple Cancer Types

Esophageal, Gastric/Gastroesophageal
II/III
Gibson, Mike
NCT03604991
ECOGGIEA2174

A Phase Ib/II Study to Evaluate the Safety, Feasibility and Efficacy of Nivolumab or Nivolumab in Combination with Azacitidine in Patients with Recurrent, Resectable Osteosarcoma

Multiple Cancer Types

Phase I, Sarcoma
I/II
Borinstein, Scott
NCT03628209
VICCPED2012

A Phase I Study with an Expansion Cohort of the Combinations of Ipilimumab, Nivolumab and Brentuximab Vedotin in Patients with Relapsed/Refractory Hodgkin Lymphoma

Multiple Cancer Types

Lymphoma, Phase I
I
Friedman, Debra
NCT01896999
COGE4412

Randomized Phase II/III Study of Nivolumab plus Ipilimumab plus Sargramostim versus Nivolumab plus Ipilimumab in Patients with Unresectable Stage III or Stage IV Melanoma

Melanoma

Melanoma
II/III
Johnson, Douglas
NCT02339571
ECOGMELEA6141